[1] Younossi ZM, Zelber-Sagi S, Lazarus JV, et al. Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis. Gastroenterology, 2025; 169, 1017-32. e2.
[2] Sadighara P, Abedini AH, Irshad N, et al. Association between non-alcoholic fatty liver disease and heavy metal exposure: a systematic review. Biol Trace Elem Res, 2023; 201, 5607−15. doi:  10.1007/s12011-023-03629-9
[3] Lazarus JV, Mark HE, Anstee QM, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol, 2022; 19, 60−78. doi:  10.1038/s41575-021-00523-4
[4] Duell PB, Welty FK, Miller M, et al. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol, 2022; 42, e168−85.
[5] Musina NN, Saprina TV, Prokhorenko TS, et al. Correlations between iron metabolism parameters, inflammatory markers and lipid profile indicators in patients with type 1 and type 2 diabetes mellitus. J Pers Med, 2020; 10, 70. doi:  10.3390/jpm10030070
[6] Chen Y, Huang HB, He XW, et al. Sex differences in the link between blood cobalt concentrations and insulin resistance in adults without diabetes. Environ Health Prev Med, 2021; 26, 42. doi:  10.1186/s12199-021-00966-w
[7] Li B, Huang Y, Luo C, et al. Inverse association of plasma molybdenum with metabolic syndrome in a Chinese adult population: a case-control study. Nutrients, 2021; 13, 4544. doi:  10.3390/nu13124544
[8] Tsuchiya H, Ebata Y, Sakabe T, et al. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. Metabolism, 2013; 62, 62−9. doi:  10.1016/j.metabol.2012.06.008
[9] Priya HK, Jha KP, Kumar N, et al. Reactive oxygen species and mitochondrial calcium’s roles in the development of atherosclerosis. Curr Pharm Des, 2024; 30, 1812−21. doi:  10.2174/0113816128303026240514111200
[10] Tripathi M, Singh BK, Zhou J, et al. Vitamin B12 and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation. J Hepatol, 2022; 77, 1246−55. doi:  10.1016/j.jhep.2022.06.033